Cramer's Mad Money - Obama's First 100 Days (4/27/09) [View article]
DuPont's bounce-back since January is highly suspect because it appears some traders and investors are NOT factoring in--
(a) the yearly dividend of $1.64 is highly likely to be slashed in the midst of DuPont's cash flow famine and systemic weakness throughout, and more significantly,
(b) the unfolding BIG BLACK HOLE in Pharma earnings. Over $1 billion yearly in DuPont Pharma PTOI will soon disappear with the sure and certain expiration of two DuPont drug patents, Cozaar® and Hyzaar®. These patents and their exclusivity are the only assets left in DuPont's fading and phased-out Pharma "platform".
$1 billion-plus yearly in PTOI goes "POOF"! ...funfun..
6 Stock Picks for a Weak Market - Barron's Interview [View article]
The stock of this shrunken chemical conglomerate is selling at 1997 prices. And the very same mediocre Management that has brought shareholders a decade of decay remain firmly entrenched in Fortress Wilmington, larding themselves with outsized pay and perks! ...funfun..
Cramer's Mad Money - Obama's First 100 Days (4/27/09) [View article]
(a) the yearly dividend of $1.64 is highly likely to be slashed in the midst of DuPont's cash flow famine and systemic weakness throughout, and more significantly,
(b) the unfolding BIG BLACK HOLE in Pharma earnings. Over $1 billion yearly in DuPont Pharma PTOI will soon disappear with the sure and certain expiration of two DuPont drug patents, Cozaar® and Hyzaar®. These patents and their exclusivity are the only assets left in DuPont's fading and phased-out Pharma "platform".
$1 billion-plus yearly in PTOI goes "POOF"! ...funfun..
6 Stock Picks for a Weak Market - Barron's Interview [View article]